Please Read Our Disclaimer

Scientific Review: CCCA Critique – Thomas COVID-19 Vaccines 6 months NEJM

Scientific Review: CCCA Critique – Thomas COVID-19 Vaccines 6 months NEJM

We present several concerns regarding the recent article by Thomas et al. (2) on the efficacy and

safety of the BNT162b2 mRNA coronavirus disease (COVID-19) vaccine, which was published in the

New England Journal of Medicine (NEJM) on November 4, 2021.

Tags: adolescents, adverse effects, adverse events, BNT162b2, CCCA, conflict of interest, COVID, COVID-19, Critique, NEJM, Pfizer, placebo, SAE, SARS-CoV-2, Scientific review, study, Thomas et al, vaccines, virology

Share:

Related Posts

Conflict of Interest Series #3 – Public-Private Piracy

Conflict of Interest Series #2 – The US Food and Drug Administration

Conflict of Interest Series #1 – Canadian Healthcare Under Siege

Search

Top Categories

WANT TO BECOME A MEMBER?

To learn more about how you can join the Canadian Covid Care Alliance click the link below.

Popular Posts

New Book: “Down the COVID-19 Rabbit Hole: Independent Scientists and Physicians Unmask the Pandemic”

Weighing the Evidence: A Response to the COVID-19 Immunity Task Force COVERED Study

Open Letter on the Safety and Effectiveness of COVID-19 Vaccines to Dr. Patrick Fandja

Protect Pregnancy & Breastfeeding Q&A

Relative vs Absolute Risk Reduction

Stay Connected

Canadian Covid Care Alliance